IP Library › Granted Patent US 10,472,380
Granted Patent B2
US 10,472,380 · App. 15/685,440 · Granted Nov 12, 2019

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

Inventors: Adam H. Brockman (Arlington, MA); Mark T. Bilodeau (Waltham, MA); Benoît Moreau (Newton, MA); Edward R. Lee (Sudbury, MA)
Assignee: PLACON THERAPEUTICS, INC.
C07F15/0093A61K9/0019A61K9/5153A61K31/555A61K9/5146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,472,380
App. No.
15/685,440
Granted
Nov 12, 2019
Kind
B2
Abstract

The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer.

Claims (1)

1. A method of inhibiting proliferation of a lung cancer cell comprising contacting the cell with an effective amount of a compound selected from a group consisting of:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: PLACON THERAPEUTICS, INC.
To: XLINK THERAPEUTICS, INC.
Reel/Frame 054215/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2017
From: BROCKMAN, ADAM H.; BILODEAU, MARK T.; MOREAU, BENOÎT; LEE, EDWARD R.
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043402/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2017
From: BLEND THERAPEUTICS, INC.
To: PLACON THERAPEUTICS, INC.
Reel/Frame 043402/0283 →
Continuity (3)
Division 14905537
Provisional Application 61846708 · Jul 16, 2013
Related Publication 20170349615A1 · Dec 7, 2017